Assessing Histology Structures by Ex Vivo MR Microscopy and Exploring the Link Between MRM-Derived Radiomic Features and Histopathology in Ovarian Cancer

Marion Tardieu, Yulia Lakhman, Lakhdar Khellaf, Maida Cardoso, Olivia Sgarbura, Pierre-Emmanuel Colombo, Mireia Crispin-Ortuzar, Evis Sala, Christophe Goze-Bac, Stephanie Nougaret, Marion Tardieu, Yulia Lakhman, Lakhdar Khellaf, Maida Cardoso, Olivia Sgarbura, Pierre-Emmanuel Colombo, Mireia Crispin-Ortuzar, Evis Sala, Christophe Goze-Bac, Stephanie Nougaret

Abstract

The value of MR radiomic features at a microscopic scale has not been explored in ovarian cancer. The objective of this study was to probe the associations of MR microscopy (MRM) images and MRM-derived radiomic maps with histopathology in high-grade serous ovarian cancer (HGSOC). Nine peritoneal implants from 9 patients with HGSOC were imaged ex vivo with MRM using a 9.4-T MR scanner. All MRM images and computed pixel-wise radiomics maps were correlated with the slice-matched stroma and tumor proportion maps derived from whole histopathologic slide images (WHSI) of corresponding peritoneal implants. Automated MRM-derived segmentation maps of tumor and stroma were constructed using holdout test data and validated against the histopathologic gold standard. Excellent correlation between MRM images and WHSI was observed (Dice index = 0.77). Entropy, correlation, difference entropy, and sum entropy radiomic features were positively associated with high stromal proportion (r = 0.97,0.88, 0.81, and 0.96 respectively, p < 0.05). MR signal intensity, energy, homogeneity, auto correlation, difference variance, and sum average were negatively associated with low stromal proportion (r = -0.91, -0.93, -0.94, -0.9, -0.89, -0.89, respectively, p < 0.05). Using the automated model, MRM predicted stromal proportion with an accuracy ranging from 61.4% to 71.9%. In this hypothesis-generating study, we showed that it is feasible to resolve histologic structures in HGSOC using ex vivo MRM at 9.4 T and radiomics.

Keywords: MRI; histology; machine learning; ovarian cancer; radiomics.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Tardieu, Lakhman, Khellaf, Cardoso, Sgarbura, Colombo, Crispin-Ortuzar, Sala, Goze-Bac and Nougaret.

Figures

Figure 1
Figure 1
Illustration of the study experimental workflow.
Figure 2
Figure 2
H&E-stained histological images (A), left) with corresponding high-resolution MR images (A), right), for 4 of the 9 resected peritoneal implants (i–iv). Magnified regions (B) of histological (left) and high-resolution MR (right) images, indicating by red and green boxes on (A). Scale bar at top right of histological images (A) is 1 mm. White and blue arrows on the histologically magnified region (B). (iv) Indicated respectively psammoma bodies and hyaline stroma.
Figure 3
Figure 3
Spatial overlaps between histological images (A) and MR images (B) for stroma and tumor portion. ROIs were manually drawn on MRM and whole slide images and then superposed in (C). Dice similarity index (DSI), stroma proportion, and signal intensity are presented in a table (D) for each ROI.
Figure 4
Figure 4
High-resolution MR image (A) of resected peritoneal implant with corresponding tissue segmentation map (B) and stromal proportion map (C), in %). Corresponding texture maps (D) for energy (i), entropy (ii), and homogeneity (iii) features. For this implant, high tumor proportion (low proportion of stroma) was associated with higher energy (from 0.029 ± 0.020 to 0.019 ± 0.014, t-test p = 0.0002), homogeneity (from 0.44 ± 0.10 to 0.38 ± 0.10, t-test p = 0.0001) and signal intensity (from 141.41 ± 28.30 to 116.09 ± 41.52, t-test p = 0.0002) scores (Figure 3). In contrast, high stromal proportion (low tumor proportion) was associated with higher entropy score (from 5.87 ± 1.00 to 6.47 ± 0.83, t-test p = 0.0002).
Figure 5
Figure 5
Pearson’s correlation plots between texture features and proportion of stroma (%), extracted from resected peritoneal implant from Figure 2. Stromal proportion map was divided into increments of 10 percentage points and mean texture values were calculated for these 10 regions. r indicates the correlation coefficient.
Figure 6
Figure 6
Stroma-rich (>50%) and -poor ((A) and predicted segmentation map from MR feature maps (B), with pixels in green where stromal proportion >50% (stroma-rich) and in red where stromal proportion <50% (stroma-poor). (C) Evaluation map with pixels correctly classified in yellow and incorrectly classified in blue. For four tumors from (i–iv).

References

    1. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. . Ovarian Cancer Statistics, 2018. CA: A Cancer J Clin (2018) 68(4):284−96. doi: 10.3322/caac.21456
    1. Lee J-M, Minasian L, Kohn EC. New Strategies in Ovarian Cancer Treatment. Cancer (2019) 125(S24):4623−9. doi: 10.1002/cncr.32544
    1. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, et al. . Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. N Engl J Med (2018) 378(3):230−40. doi: 10.1056/NEJMoa1708618
    1. Jacob F, Marchetti RL, Kind AB, Russell K, Schoetzau A, Heinzelmann-Schwarz VA. High-Grade Serous Peritoneal Cancer Follows a High Stromal Response Signature and Shows Worse Outcome Than Ovarian Cancer. Mol Oncol (2021) 91–103. doi: 10.1002/1878-0261.12811
    1. Dai G, Liang K, Xiao Z, Yang Q, Yang S-G. A Meta-Analysis on the Diagnostic Value of Diffusion-Weighted Imaging on Ovarian Cancer. J Buon (2019) 2333–40.
    1. Deen SS, Priest AN, McLean MA, Gill AB, Brodie C, Crawford R, et al. . Diffusion Kurtosis MRI as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy in High Grade Serous Ovarian Cancer. Sci Rep (2019) 9(1):10742. doi: 10.1038/s41598-019-47195-4
    1. Rizzo S, De Piano F, Buscarino V, Pagan E, Bagnardi V, Zanagnolo V, et al. . Pre-Operative Evaluation of Epithelial Ovarian Cancer Patients: Role of Whole Body Diffusion Weighted Imaging MR and CT Scans in the Selection of Patients Suitable for Primary Debulking Surgery. A Single-Centre Study. Eur J Radiol (2020) 123:108786. doi: 10.1016/j.ejrad.2019.108786
    1. Kyriazi S, Collins DJ, Messiou C, Pennert K, Davidson RL, Giles SL, et al. . Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response With Diffusion-Weighted MR Imaging—Value of Histogram Analysis of Apparent Diffusion Coefficients. Radiology (2011) 261(1):182−92. doi: 10.1148/radiol.11110577
    1. Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. . Radiomics: The Process and the Challenges. Magn Reson Imaging (2012) 30(9):1234−48. doi: 10.1016/j.mri.2012.06.010
    1. Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RGPM, Granton P, et al. . Radiomics: Extracting More Information From Medical Images Using Advanced Feature Analysis. Eur J Cancer (2012) 48(4):441−6. doi: 10.1016/j.ejca.2011.11.036
    1. Rizzo S, Botta F, Raimondi S, Origgi D, Buscarino V, Colarieti A, et al. . Radiomics of High-Grade Serous Ovarian Cancer: Association Between Quantitative CT Features, Residual Tumour and Disease Progression Within 12 Months. Eur Radiol (2018) 28(11):4849−59. doi: 10.1007/s00330-018-5389-z
    1. Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. . Ovarian Cancer: An Update on Imaging in the Era of Radiomics. Diagn Interventional Imaging (2019) 100(10):647−55. doi: 10.1016/j.diii.2018.11.007
    1. Song X, Ren J-L, Zhao D, Wang L, Ren H, Niu J. Radiomics Derived From Dynamic Contrast-Enhanced MRI Pharmacokinetic Protocol Features: The Value of Precision Diagnosis Ovarian Neoplasms. Eur Radiol (2021) 31(1):368−78. doi: 10.1007/s00330-020-07112-0
    1. Vargas HA, Veeraraghavan H, Micco M, Nougaret S, Lakhman Y, Meier AA, et al. . A Novel Representation of Inter-Site Tumour Heterogeneity From Pre-Treatment Computed Tomography Textures Classifies Ovarian Cancers by Clinical Outcome. Eur Radiol (2017) 27(9):3991−4001. doi: 10.1007/s00330-017-4779-y
    1. Athavale R, Thomakos N, Godfrey K, Kew F, Cross P, Lopes ADB, et al. . The Effect of Epithelial and Stromal Tumor Components on FIGO Stages III and IV Ovarian Carcinosarcomas Treated With Primary Surgery and Chemotherapy. Int J Gynecologic Cancer (2007) 17(5). doi: 10.1111/j.1525-1438.2007.00919.x
    1. Labiche A, Heutte N, Herlin P, Chasle J, Gauduchon P, Elie N. Stromal Compartment as a Survival Prognostic Factor in Advanced Ovarian Carcinoma. Int J Gynecologic Cancer (2010) 20(1). doi: 10.1111/IGC.0b013e3181bda1cb
    1. Greenaway J, Moorehead R, Shaw P, Petrik J. Epithelial–stromal Interaction Increases Cell Proliferation, Survival and Tumorigenicity in a Mouse Model of Human Epithelial Ovarian Cancer. Gynecologic Oncol (2008) 108(2):385−94. doi: 10.1016/j.ygyno.2007.10.035
    1. Lu H, Arshad M, Thornton A, Avesani G, Cunnea P, Curry E, et al. . A Mathematical-Descriptor of Tumor-Mesoscopic-Structure From Computed-Tomography Images Annotates Prognostic- and Molecular-Phenotypes of Epithelial Ovarian Cancer. Nat Commun (2019) 10(1):764. doi: 10.1038/s41467-019-08718-9
    1. Dashevsky BZ, D’Alfonso T, Sutton EJ, Giambrone A, Aronowitz E, Morris EA, et al. . The Potential of High Resolution Magnetic Resonance Microscopy in the Pathologic Analysis of Resected Breast and Lymph Tissue. Sci Rep (2015) 5:17435. doi: 10.1038/srep17435
    1. Fan X, Haney CR, Agrawal G, Pelizzari CA, Antic T, Eggener SE, et al. . High-Resolution MRI of Excised Human Prostate Specimens Acquired With 9.4T in Detection and Identification of Cancers: Validation of a Technique. J Magn Reson Imaging (2011) 34(4):956−61. doi: 10.1002/jmri.22745
    1. Durand M, Jain M, Robinson B, Aronowitz E, Douahy YE, Leung R, et al. . Magnetic Resonance Microscopy may Enable Distinction Between Normal Histomorphological Features and Prostate Cancer in the Resected Prostate Gland. BJU Int (2017) 119(3):414−23. doi: 10.1111/bju.13523
    1. Heidkamp J, Hoogenboom M, Kovacs IE, Veltien A, Maat A, Sedelaar JPM, et al. . Ex Vivo MRI Evaluation of Prostate Cancer: Localization and Margin Status Prediction of Prostate Cancer in Fresh Radical Prostatectomy Specimens. J Magn Reson Imaging (2018) 47(2):439−48. doi: 10.1002/jmri.25785
    1. Martínez-Bisbal MC, Martínez-Granados B, Rovira V, Celda B, Esteve V. Magnetic Resonance Spectroscopy and Imaging on Fresh Human Brain Tumor Biopsies at Microscopic Resolution. Anal Bioanal Chem (2015) 407(22):6771−80. doi: 10.1007/s00216-015-8847-3
    1. Coillot C, Sidiboulenouar R, Nativel E, Zanca M, Alibert E, Cardoso M, et al. . Signal Modeling of an MRI Ribbon Solenoid Coil Dedicated to Spinal Cord Injury Investigations. J Sens Sens Syst (2016) 5:137−45. doi: 10.5194/jsss-5-137-2016
    1. Mayerhoefer ME, Szomolanyi P, Jirak D, Berg A, Materka A, Dirisamer A, et al. . Effects of Magnetic Resonance Image Interpolation on the Results of Texture-Based Pattern Classification: A Phantom Study. Invest Radiol (2009) 44(7):405−11. doi: 10.1097/RLI.0b013e3181a50a66
    1. Zwanenburg A, Leger S, Vallières M, Löck S. Initiative for the IBS. Image Biomarker Standardisation Initiative. arXiv (2016) 161207003. doi: 10.1148/radiol.2020191145
    1. Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. . 3d Slicer as an Image Computing Platform for the Quantitative Imaging Network. Magn Reson Imaging (2012) 30(9):1323−41. doi: 10.1016/j.mri.2012.05.001
    1. Haralick RM, Shanmugam K, Dinstein I. Textural Features for Image Classification. IEEE Trans Syst Man Cybern (1973) SMC-3(6):610−21. doi: 10.1109/TSMC.1973.4309314
    1. Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, et al. . QuPath: Open Source Software for Digital Pathology Image Analysis. Sci Rep (2017) 7(1):16878. doi: 10.1038/s41598-017-17204-5
    1. Gibson E, Crukley C, Gaed M, Gómez JA, Moussa M, Chin JL, et al. . Registration of Prostate Histology Images to Ex Vivo MR Images via Strand-Shaped Fiducials. J Magn Reson Imaging (2012) 36(6):1402−12. doi: 10.1002/jmri.23767
    1. Lopater J, Colin P, Beuvon F, Sibony M, Dalimier E, Cornud F, et al. . Real-Time Cancer Diagnosis During Prostate Biopsy: Ex Vivo Evaluation of Full-Field Optical Coherence Tomography (FFOCT) Imaging on Biopsy Cores. World J Urol (2016) 34(2):237−43. doi: 10.1007/s00345-015-1620-6

Source: PubMed

3
Abonnere